Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
2017 ◽
Vol Volume 11
◽
pp. 2239-2250
◽
2019 ◽
Vol 42
(4)
◽
pp. 573-579
◽
Keyword(s):
2010 ◽
Vol 25
(4)
◽
pp. 738-744
◽
Keyword(s):
2019 ◽
Vol 25
(13)
◽
pp. 4091-4103
◽
Keyword(s):
2008 ◽
Vol 14
(23)
◽
pp. 7614-7623
◽
Keyword(s):